Viewing Study NCT04123795


Ignite Creation Date: 2025-12-24 @ 2:20 PM
Ignite Modification Date: 2026-01-01 @ 8:30 AM
Study NCT ID: NCT04123795
Status: RECRUITING
Last Update Posted: 2025-12-17
First Post: 2019-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module